Aligos Therapeutics, Inc. (ALGS) Dividend History

Company News

• Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  Aligos Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted a non-qualified stock option to a newly hired employee as an inducement to join the company.

  GlobeNewswire Inc.
• AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC - Zacks Investment Research

  AstraZeneca's lung cancer drug Tagrisso has been approved by the European Commission for use in combination with chemotherapy as a first-line treatment for advanced EGFR-mutated non-small cell lung cancer. The approval was based on positive data from the FLAURA2 study, which showed Tagrisso plus chemotherapy reduced the risk of disease progression or death by 38% compared to Tagrisso monotherapy.

  Zacks Investment Research

  Featured Companies: ACRV
• Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

  Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter. The company said net revenues decreased by 5.9% year-over-year to RMB3,042.8 million ($417.1 million) during the third quarter. Non-GAAP diluted net income per ADS rose to RMB3.05 (US$0.42) from RMB2.60 in the year-ago period. Hello Group shares rose 8.1% to $7.10 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers MBIA Inc. (NYSE: MBI) shares rose 54.8% to $11.43 in pre-market trading after the company announced it declared an extraordinary cash dividend on MBIA common stock of $8.00 per share. Exicure, Inc. (NASDAQ: XCUR) shares gained 53.4% to $0.6597 in pre-market trading after gaining more than 5% on Thursday. FLJ Group Limited (NASDAQ: FLJ) rose 16.7% to $2.31 in pre-market trading after falling over 56% on Thursday. Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 11.4% to $0.2198 in pre-market trading after falling 4% on Thursday. Ault Alliance, Inc.(NYSE: AULT) gained 11% to $0.1020 in pre-market trading after falling around 10% on Thursday. Aligos Therapeutics, Inc. (NASDAQ: ALGS) shares climbed 10.5% to $0.7184 in pre-market ...

  Benzinga

  Featured Companies: CLEU CYN GDHG MBI RH SLDB SLS SNOA THAR XCUR
• 4 Penny Stocks To Buy According To Analysts & Targets Over 600%

  Analysts have put these on their list of penny stocks to buy. Do you agree? The post 4 Penny Stocks To Buy According To Analysts & Targets Over 600% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: ARDX GERN